Microtechnology in Space Bioreactors

Space biology is a young and rapidly developing discipline comprising basic research and biotechnology. In the next decades it will play a prominent role in the International Space Station (ISS). Therefore, there is an increasing demand for sophisticated instrumentation to satisfy the requirements of the future projects in space biology. Bioreactors will be needed to supply fresh living material (cells and tissues) either to study still obscure basic biological mechanisms or to develop profitable bioprocesses which will take advantage of the peculiar microgravity conditions. Since more than twenty years, the Space Biology Group of the ETHZ is carrying out research projects in space (Space Shuttle/Spacelab, MIR Station, satellites, and sounding rockets) that involve also the development of space-qualified instrumentation. In the last ten years we have developed, in collaboration with Mecanex SA, Nyon, and the Institute of Microtechnology of the University of Neuchatel, a space bioreactor for the continuous culture of yeast cells under controlled conditions. Sensors, pH control, nutrients pump and fluid flowmeter are based on state-of-the-art silicon technology. After two successful space flights, a further improved version is presently prepared for a flight in the year 2000

Development of a Space Bioreactor using Microtechnology

A miniature bio-reactor for the cultivation of cells aboard Spacelab is presented. Yeast cells are grown in a 3 milliliter reactor chamber. A supply of fresh nutrient medium is provided by a piezo-electric silicon micro-pump. In the reactor, pH, temperature, and redox potential are monitored and the pH is regulated at a constant value. The complete instrument is fitted in a standard experiment container of 63 x 63 x 85 mm. The bioreactor was used on the IML-2 mission in July 1994 and is being refurbished for a reflight in the spring of 1996

Rapid alterations of cell cycle control proteins in human T lymphocytes in microgravity

In our study we aimed to identify rapidly reacting gravity-responsive mechanisms in mammalian cells in order to understand if and how altered gravity is translated into a cellular response. In a combination of experiments using "functional weightlessness" provided by 2D-clinostats and real microgravity provided by several parabolic flight campaigns and compared to in-flight-1g-controls, we identified rapid gravity-responsive reactions inside the cell cycle regulatory machinery of human T lymphocytes. In response to 2D clinorotation, we detected an enhanced expression of p21 Waf1/Cip1 protein within minutes, less cdc25C protein expression and enhanced Ser147-phosphorylation of cyclinB1 after CD3/CD28 stimulation. Additionally, during 2D clinorotation, Tyr-15-phosphorylation occurred later and was shorter than in the 1 g controls. In CD3/CD28-stimulated primary human T cells, mRNA expression of the cell cycle arrest protein p21 increased 4.1-fold after 20s real microgravity in primary CD4+ T cells and 2.9-fold in Jurkat T cells, compared to 1 g in-flight controls after CD3/CD28 stimulation. The histone acetyltransferase (HAT) inhibitor curcumin was able to abrogate microgravity-induced p21 mRNA expression, whereas expression was enhanced by a histone deacetylase (HDAC) inhibitor. Therefore, we suppose that cell cycle progression in human T lymphocytes requires Earth gravity and that the disturbed expression of cell cycle regulatory proteins could contribute to the breakdown of the human immune system in space

Space Biology Group: Basic Research, Biotechnology, Tissue Engineering, and Instrument Development

At the beginning of space flight, the investigations were oriented essentially toward the health of the astronauts. But in the last three decades space biology has evolved from 'try-and-see' experiments to sophisticated basic and applied research with well-based hypotheses as well as studies on the use of low gravity in biological applications. In 1977 the Space Biology Group of the Swiss Federal Institute of Technology, Zürich, began its activities in space research. A summary of the experiments performed to date, from basic research on the human immune system to the development of sophisticated instruments for biotechnology and medical application, is presented here

Influence of microgravity on mitogen binding and cytoskeleton in Jurkat cells

The effects of microgravity on Jurkat cells — a T-lymphoid cell line — was studied on a sounding rocket flight. An automated pre-programmed instrument permitted the injection of fluorescent labelled concanavalin A (Con A), culture medium and/or fixative at given times. An in-flight 1 g centrifuge allowed the comparison of the data obtained in microgravity with a 1 g control having the same history related to launch and re-entry. After flight, the cells fixed either at the onset of microgravity or after a 12 minute incubation time with fluorescent concanavalin A were labelled for vimentin and actin and analysed by fluorescence microscopy. Binding of Con A to Jurkat cells is not influenced by microgravity, whereas patching of the Con A receptors is significantly lower. A significant higher number of cells show changes in the structure of vimentin in microgravity. Most evident is the appearance of large bundles, significantly increased in the microgravity samples. No changes are found in the structure of actin and in the colocalisation of actin on the inner side of the cell membrane with the Con A receptors after binding of the mitogen

Signal transduction in T lymphocytes - a comparison of the data from space, the free fall machine and the random positioning machine

In this paper we discuss the effect of microgravity on T cells and we present the data of studies with two new machines for 0 g simulations. Several experiments in space show that mitogenic T cell activation is lost at 0 g. Immunocytochemistry indicates that such effect is associated with changes of the cytoskeleton. Biochemical studies suggest that the lack of expression of the interleukin-2 receptor is one of the major causes of the loss of activity. In fact, interleukin-2 is the third signal required for full activation. In order to deepen our investigations we are now working with the free-fall machine, FFM, invented by D. Mesland, and with the random positioning machine, RPM, or three-dimensional clinostat, developed by T. Hoson. The FFM produces periods of free-fall lasting approximately 800 ms followed by bounces of 15–30 g lasting 45–60 ms. The RPM eliminates the effect of gravity by rotating biological specimen randomly around two orthogonal axes. While the FFM failed to reproduce the results obtained with T lymphocytes in space, the data from the RPM are in good agreement with those in real microgravity. In fact, the inhibition of the mitotic index in the RPM is 89% compared to static controls. The RPM (as the FFM) can carry markedly larger specimen than the fast rotating clinostat and thus allows to conduct comprehensive studies to select suitable biological objects for further investigations in space